Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jan 7, 2025; 31(1): 100750
Published online Jan 7, 2025. doi: 10.3748/wjg.v31.i1.100750
Table 3 Postoperative data for patients in both groups, n (%)

Overall (n = 256)
Conventional LLR (n = 150)
Novel LLR (n = 106)
P value
90 days mortality
    No256 (100.0)150 (100.0)106 (100.0)
    Postoperative hospital stays, day5.36 ± 1.895.90 ± 2.174.59 ± 1.02< 0.001
Readmission1.000
    No255 (99.6)149 (99.3)106 (100.0)
    Yes1 (0.4)1 (0.7)0 (0.0)
Recurrence0.636
    No254 (99.2)148 (98.7)106 (100.0)
    Yes2 (0.8)2 (1.3)0 (0.0)
Follow up months10 (5, 15)10 (5, 15)11 (5, 16)0.346
Liver failure1.000
    No255 (99.6)149 (99.3)106 (100.0)
    Yes1 (0.4)1 (0.7)0 (0.0)
Ascites0.382
    No253 (98.8)147 (98.0)106 (100.0)
    Yes3 (1.2)3 (2.0)0 (0.0)
Clavien-Dindo complication grade0.636
    < IIIa254 (99.2)148 (98.7)106 (100.0)
    ≥ IIIa2 (0.8)2 (1.3)0 (0.0)